Screening and Prevention
In the last decade, colonoscopy has come into widespread use in the United States. Colonoscopies are used to detect precancerous polyps and colorectal cancer. They can also help gastroenterologists evaluate changes in bowel habits, abdominal pain, anal bleeding and weight loss.
Because of this successful intervention, precancerous polyps can be detected and removed early, thereby decreasing the incidence of colon cancer. Colorectal cancer screening accounts for 40% of clinical activity in the PAMF gastroenterology departments.
PAMF consistently garners the prestigious Integrated Healthcare Association (IHA) "Top Performers" award for high colon cancer screening rates that lead to early detection and better outcomes.
Colon Cancer Screening
- Measure: Patients 50 to 75 who have received appropriate colorectal cancer screenings
National Average: 50%
- Measure: Detection and removal of multiple colon polyps, decreasing
PAMF*: Men - 50%, Women - 42%
National Average: Men - 25%, Women - 15%
- Measure: Ability to view the entire colon (reaching the cecum)
National Average: 95%
- Measure: Average colonoscopy exam time (longer times increase polyp detection)
PAMF*: 14 minutes
National Average: 6 minutes
- Measure: Complication rates
National Average: 1.32%
- Measure: Patient satisfaction with GI doctors
National Average: 91%